Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 12Recruiting 4Unknown 2Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 1780Triple Negative Breast Neoplasms 299Ovarian Neoplasms 136Lung Neoplasms 115Colorectal Neoplasms 115Neoplasms 106Prostatic Neoplasms 103Carcinoma, Non-Small-Cell Lung 101Neoplasm Metastasis 96Stomach Neoplasms 81Pancreatic Neoplasms 78Melanoma 74Endometrial Neoplasms 65Head and Neck Neoplasms 60Uterine Cervical Neoplasms 56Squamous Cell Carcinoma of Head and Neck 50Colonic Neoplasms 45Esophageal Neoplasms 42Sarcoma 41Carcinoma, Intraductal, Noninfiltrating 41Motor Activity 37HER2-positive Breast Cancer 34Urinary Bladder Neoplasms 33Liver Neoplasms 31Carcinoma, Renal Cell 30Brain Neoplasms 28Advanced Breast Cancer 25Lymphedema 24Kidney Neoplasms 24Carcinoma, Transitional Cell 23

Interventions

Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Breast Cancer Screening × Breast × Clear all
NCT07411443 2026-02-13

AI-Enhanced Imaging in Population Breast Cancer Screening

Fudan University

Phase NA Recruiting
16,000 enrolled
Breast

Breast Cancer Screening

NCT06934239 2025-11-26

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Jonsson Comprehensive Cancer Center

Phase 4 Recruiting
400,000 enrolled
Breast

Breast Cancer Screening

NCT05841355 2025-07-10

MADRE

University of Illinois at Chicago

Phase NA Recruiting
600 enrolled
Breast

Breast Cancer Screening

NCT06876610 2025-03-14

Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer

Geneplus-Beijing Co. Ltd.

Recruiting
200 enrolled
Breast

Breast Cancer Screening

Data powered by HemOnc (CC BY 4.0) Colophon âš¡